A retrospective study of the incidence and characterization of weight gain associated with MEK inhibitors in pediatric patients
Latest Information Update: 08 Mar 2023
At a glance
- Drugs Selumetinib (Primary) ; Trametinib (Primary)
- Indications Astrocytoma; Glioma; Neurofibromatoses
- Focus Adverse reactions
Most Recent Events
- 01 Apr 2023 Results published in the Pediatric Blood and Cancer
- 08 Mar 2023 New trial record